South Korea Biomaterials in Healthcare Market Report 2022 to 2030

South Korea Biomaterials in Healthcare Market Analysis

$ 3999

The South Korea Biomaterials Healthcare Market is expected to witness growth from $2.28 Bn in 2022 to $6.60 Bn in 2030 with a CAGR of 14.20% for the forecasted year 2022-2030. With a large percentage of elderly residents, South Korea has one of the world's fastest aging populations. As a result, there is a rising need for biomaterials and medical equipment. The market is segmented by type and by application. Some key players in this market include: Kolon Life Science, Sewon Cellontech, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

ID: IN10KRMD003 CATEGORY: Medical Devices GEOGRAPHY: South Korea AUTHOR: Jigyasu Bhandari

Buy Now

South Korea Biomaterials in Healthcare Market Executive Analysis

The South Korea Biomaterials Healthcare Market size is at around $2.28 Bn in 2022 and is projected to reach $6.60 Bn in 2030, exhibiting a CAGR of 14.20% during the forecast period. The GDP of South Korea is anticipated to be $1.81 trillion in 2021. South Koreans spent about $3.9 thousand per individual on health in 2021. Koreans paid $3.6 thousand annually on average in the previous year. Despite an increase, per-person expenditure is still less than the 2019 OECD average of more than $4,000.

Biocompatibility, the capacity to integrate with living tissues, and the possibility for controlled drug release are just a few of the many advantages and benefits of biomaterials. Additionally, the use of biomaterials can enhance patient outcomes, lower the chance of infection, and lessen the need for subsequent surgeries. Medical devices that can substitute or supplement harmed or sick tissues, like implants and prosthetics, are developed using biomaterials. Biomaterials, for instance, can be used to create cardiac valves, dental implants, and hip and knee implants. In tissue engineering, where cells are grown on a scaffold made of biomaterials to make tissues and organs, biomaterials are used. By offering an infinite supply of organs and tissues for transplantation, this technology has the potential to revolutionize the field of transplantation. Drugs can be delivered using biomaterials, allowing for a regulated release over time. By delivering medications directly to the site of action, this technology can increase the effectiveness of medications and lower their adverse effects. To encourage tissue regeneration and healing, biomaterials can be used in regenerative medicine. Biomaterials, for instance, can be used to spur the development of new blood vessels, encourage bone growth, and restore cartilage that has been damaged.

south korea biomaterials in healthcare market

Market Dynamics

Market Growth Drivers

An increasing number of international patients are choosing South Korea as a destination for medical tourism in order to receive treatment there. High-quality medical equipment and biomaterials that can produce superior results are in high demand as a result of this tendency. With a large percentage of elderly residents, South Korea has one of the world's fastest aging populations. As a result, there is a rising need for biomaterials and medical equipment, such as implants, prosthetic limbs, and tissue engineering solutions, that can enhance elders' quality of life. The demand for healthcare services and treatments is rising as the populace ages. This demand is influencing the creation of novel biomaterials and medical equipment that can treat a variety of healthcare issues, from acute injuries to chronic diseases. The advanced technology sector in South Korea is well-known, and this knowledge is being applied to the creation of cutting-edge medical technology and biomaterials. In the South Korean biomaterials healthcare market, innovations in fields like tissue engineering, drug delivery, and regenerative medicine are fueling growth and opening up new possibilities for manufacturers.

Market Restraints

The South Korean biomaterials market as well as the wider healthcare sector may be impacted by economic unpredictability and market volatility. Geopolitical risks, currency fluctuations, and trade disputes can all hinder market expansion and pose challenges for manufacturers in South Korea biomaterials healthcare market. Due to regulatory limitations or reimbursement caps, some biomaterials and medical devices only have restricted market access. This may restrict the size of the market for particular goods and make it challenging for producers to attain scale.

Competitive Landscape

Key Players

Kolon Life Science (KOR)
Sewon Cellontech (KOR)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Recent Notable Deals

2022: Kolon Life Science and Meditox, a South Korean manufacturer of botulinum toxin goods, have partnered strategically. In accordance with the agreement, Kolon Life Science will give Meditox access to the manufacturing equipment and raw materials needed to make products containing botulinum toxin.

Healthcare Policies and Regulatory Landscape

In South Korea, Regulation of biomaterials is carried out by organizations like the Korean Ministry of Food and Drug Safety (MFDS), the European Medicines Agency, and the U.S. Food and Drug Administration (FDA). Before being marketed to patients, these organizations demand that medical devices satisfy specific safety and efficacy standards. Manufacturers of medical devices must adhere to stringent manufacturing processes and quality control procedures in order to comply with Good Manufacturing Practices (GMP) rules and produce safe and effective products. GMP rules are enforced by regulatory bodies and are intended to guarantee that medical devices are produced in accordance with uniformly high standards of quality. In the South Korean healthcare market, makers of biomaterials are required to provide accurate and understandable labeling and advertising for their products. Information on the product's intended use, possible risks and side effects, and any safety measures that patients or medical professionals should take when using the product are all included in this.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the South Korea market in 2019. The growing geriatric population South Korealy is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.